[Strategy for the identification of amplified genes in tumors]

Man-li Luo1, Ming-rong Wang

  • 1National Laboratory of Molecular Oncology, Cancer Institute, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100021 P.R. China.

Insights

Identifying amplified genes in tumors aids oncogene discovery. Techniques like comparative genomic hybridization and quantitative PCR help characterize these genes and their role in cancer development.

Area of Science:

  • Oncology
  • Genomics
  • Molecular Biology

Context:

  • Genomic DNA amplification is a common hallmark of various tumors.
  • Identifying amplified genes is crucial for discovering novel oncogenes driving specific cancers.

Purpose:

  • To outline methods for defining amplified genomic regions in tumors.
  • To detail techniques for characterizing gene copy number alterations, mRNA, and protein levels.
  • To explain how to demonstrate the role of amplified genes in tumor pathogenesis.

Summary:

  • Array-based comparative genomic hybridization and restriction landmark genomic scanning define amplified regions.
  • Quantitative PCR and immunohistochemistry characterize copy number, mRNA, and protein levels of target genes.
  • Functional studies using transfection, RNA interference, or other molecular techniques elucidate the role of amplified genes in tumorigenesis.

Impact:

  • Facilitates the discovery of new oncogenes and potential therapeutic targets.
  • Provides a framework for understanding the genetic basis of tumor development.
  • Enhances the identification of biomarkers for cancer diagnosis and prognosis.

Related Concept Videos